Cargando…
Tocilizumab for the treatment of giant cell arteritis in Scotland: a report on behalf of the Scottish Society for Rheumatology standards subgroup
OBJECTIVES: The aim was to describe a modern National Health Service (NHS) Scotland cohort of patients with GCA over 12 months of care to include clinical presentation, practices relating to assessment and treatment, and specifically, the use of tocilizumab. METHODS: A multicentre audit of patients...
Autores principales: | Cronin, Owen, Preston, Hannah, Fahmy, Heba, Kuske, Barbara, Singh, Malinder, Scott, Naomi, Kerrigan, Sean, Moran, Lucy, Harvie, John, Harris, Helen, Hauser, Barbara, McKay, Neil D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969593/ https://www.ncbi.nlm.nih.gov/pubmed/35368971 http://dx.doi.org/10.1093/rap/rkac017 |
Ejemplares similares
-
Design of the Tocilizumab in Giant Cell Arteritis Trial
por: Unizony, Sebastian H., et al.
Publicado: (2013) -
Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022) -
Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022) -
42. Large vessel vasculitis with rapidly expanding aortic aneurysm
por: Singh, Malinder Kaur Baldeve, et al.
Publicado: (2019) -
Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)